Oppenheimer Asset Management Inc. Buys 7,350 Shares of Phibro Animal Health Corp (NASDAQ:PAHC)

Oppenheimer Asset Management Inc. increased its stake in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 3,930.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,537 shares of the company’s stock after acquiring an additional 7,350 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Phibro Animal Health were worth $240,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of PAHC. Dimensional Fund Advisors LP boosted its position in shares of Phibro Animal Health by 3.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 531,387 shares of the company’s stock worth $17,089,000 after acquiring an additional 20,108 shares during the last quarter. BNP Paribas Arbitrage SA lifted its position in Phibro Animal Health by 926.8% during the first quarter. BNP Paribas Arbitrage SA now owns 4,713 shares of the company’s stock valued at $156,000 after purchasing an additional 4,254 shares during the last quarter. Janus Henderson Group PLC lifted its position in Phibro Animal Health by 1,961.2% during the first quarter. Janus Henderson Group PLC now owns 230,340 shares of the company’s stock valued at $7,601,000 after purchasing an additional 219,165 shares during the last quarter. Rhumbline Advisers lifted its position in Phibro Animal Health by 1.0% during the first quarter. Rhumbline Advisers now owns 58,969 shares of the company’s stock valued at $1,946,000 after purchasing an additional 610 shares during the last quarter. Finally, Comerica Bank lifted its position in Phibro Animal Health by 2.8% during the first quarter. Comerica Bank now owns 19,961 shares of the company’s stock valued at $674,000 after purchasing an additional 550 shares during the last quarter. Hedge funds and other institutional investors own 51.74% of the company’s stock.

PAHC has been the subject of several research reports. ValuEngine lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research report on Wednesday, August 28th. Morgan Stanley upgraded shares of Phibro Animal Health from an “underweight” rating to an “equal” rating and increased their price objective for the company from $21.00 to $30.00 in a research report on Thursday, September 5th. They noted that the move was a valuation call. BidaskClub downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Friday, August 30th. TheStreet downgraded shares of Phibro Animal Health from a “b-” rating to a “c+” rating in a research note on Tuesday. Finally, Guggenheim began coverage on shares of Phibro Animal Health in a research note on Thursday, May 23rd. They issued a “neutral” rating on the stock. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $26.60.



In related news, Director E Thomas Corcoran purchased 5,000 shares of Phibro Animal Health stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average price of $21.21 per share, with a total value of $106,050.00. Following the purchase, the director now directly owns 15,000 shares of the company’s stock, valued at approximately $318,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 50.29% of the company’s stock.

Shares of PAHC traded up $0.40 during midday trading on Friday, hitting $21.36. The stock had a trading volume of 3,093 shares, compared to its average volume of 316,998. Phibro Animal Health Corp has a 1 year low of $20.00 and a 1 year high of $44.99. The firm has a market cap of $843.45 million, a PE ratio of 14.02, a price-to-earnings-growth ratio of 4.15 and a beta of 0.82. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.02 and a quick ratio of 1.74. The stock’s 50 day moving average is $27.76 and its 200 day moving average is $30.30.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Tuesday, August 27th. The company reported $0.33 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.34 by ($0.01). The firm had revenue of $203.90 million during the quarter, compared to analysts’ expectations of $206.00 million. Phibro Animal Health had a net margin of 6.59% and a return on equity of 29.99%. The company’s revenue was down 3.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.46 EPS. As a group, equities research analysts expect that Phibro Animal Health Corp will post 1.12 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.25%. The ex-dividend date is Tuesday, September 3rd. Phibro Animal Health’s dividend payout ratio is presently 31.37%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

See Also: Day Trading

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.